Skip to main content
Bladder Cancer Care

Expert Bladder Cancer Treatment, Close to Home

Bladder cancer is often detected early because it frequently produces hematuria (blood in the urine), prompting patients to seek evaluation. Our multidisciplinary team provides comprehensive care from diagnosis through treatment and survivorship, with expertise in bladder preservation, radical cystectomy coordination, chemotherapy, and immunotherapy.

📞 Call 615-460-3803
Request a Consultation
Understanding Bladder Cancer

Bladder Cancer Basics

Bladder cancer is more common in men than women and often diagnosed in its earlier stages because blood in the urine prompts medical evaluation. Most bladder cancers are urothelial carcinoma (transitional cell), though squamous cell and adenocarcinoma variants also occur. Disease stage and grade guide treatment decisions, with options ranging from resection inside the bladder and insertion of immune or chemical treatment into the bladder by urologist for early stage bladder cancer and for more advanced cancers individualized approach that may include immunotherapy, chemotherapy, surgery, or radiation. Our team specializes in multidisciplinary coordination to provide the best outcomes at every stage.

Early Signs of Bladder Cancer

Hematuria (blood in the urine) is the most common symptom of bladder cancer and is usually the first sign. Early detection significantly improves outcomes often done with urine testing and urologic procedures. In advanced disease precision medicine including genetic testing to understand the biology of your individual cancer can help guide treatment. Any blood in the urine, whether visible or found on urinalysis, warrants professional evaluation.

Possible Signs
  • Blood in the urine (visible or microscopic)
  • Increased urinary frequency
  • Urinary urgency
  • Pain or burning during urination
  • Lower back or pelvic pain
  • Recurrent urinary tract infections
Important to Know

Early bladder cancer often causes hematuria with little or no pain, which is exactly why any blood in the urine deserves evaluation. Bladder cancer is diagnosed roughly 3-4 times more often in men than women. Early detection significantly improves outcomes.

Bladder Cancer Treatment Options

Treatment depends on stage, grade, and patient factors. Our multidisciplinary team discusses all guideline-recommended options:

  • Transurethral Resection of Bladder Tumor (TURBT)
  • Intravesical Therapy
  • Radical Cystoprostatectomy
  • Radiation Therapy
  • Chemotherapy
  • Immunotherapy
  • Combination Therapy
  • Clinical Trials
Frequently Asked Questions

Common Questions About Bladder Cancer

Does blood in the urine always mean cancer?
No. Blood in the urine can result from infection, kidney stones, enlarged prostate, or other benign conditions. However, any blood in the urine should be evaluated by a physician. Only a cystoscopy and biopsy can definitively determine the cause.
What is the difference between non-muscle-invasive and muscle-invasive bladder cancer?
Non-muscle-invasive bladder cancer (stages 0, 1) is limited to the bladder lining and is treated with TURBT and intravesical therapy. Muscle-invasive disease (stage 2) invades the bladder muscle and typically requires more aggressive treatment including chemotherapy, surgery, or radiation. Our team coordinates all options.
What is bladder preservation therapy?
Bladder preservation uses TURBT, radiation therapy, and chemotherapy together to avoid removing the bladder while achieving similar outcomes to surgery in selected patients. This approach preserves continence and quality of life for appropriate candidates.
What happens after bladder removal surgery?
When the bladder is removed, urine must be diverted into a new reservoir created from bowel tissue (urinary diversion or neobladder). Our team works with patients and family to understand all options and coordinate perioperative care with urology partners and supportive services.
What is immunotherapy for bladder cancer?
Immunotherapy uses checkpoint inhibitors that activate the immune system to recognize and attack cancer cells. These are approved for stage II as well as locally advanced and metastatic bladder cancer and represent an important advance in treatment, often with better tolerance than traditional chemotherapy.
Get started

Request a Consultation

Our patient care coordinator will work with you personally to gather your medical records and schedule your multidisciplinary clinic visit. Call us directly or send us a few details and someone will reach out to help schedule your visit.

📞 Call 615-460-3803